CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association Cardiopulmonary Exercise Testing: What Is its Value? Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design

Clinical Trial26 Sep 2019

JOURNAL:Circulation. Article Link

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial

S Windecker , RD Lopes, AUGUSTUS Investigators et al. Keywords: antithrombotic therapy; atrial fibrillation; ACS patients; safety and efficacy

FULL TEXT PDF